Clinical Trials Logo

Clinical Trial Summary

72 hours after lung transplantation, patients undergo a positron emission tomography (PET) scan and a computed tomography (CT) scan in order to analyse lung function and morphology.

Aim of the study is to analyse complications onset (in particular primary graft dysfunction), and evaluate 90 days mortality after lung transplantation.


Clinical Trial Description

Pulmonary transplantation is considered as a lifesaving procedure in end-stage pulmonary disease. However morbidity and mortality after lung transplantation are still significant.

Primary graft dysfunction (PGD) is the main cause of early death. PGD is similar to acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS): oxygenation is compromised, pulmonary compliance is decreased, chest Rx shows several infiltrates, and alveolar damage is present.

25% of patients develops PGD within 72 hours from transplantation and 30 days mortality is eight times higher in patients who develop PGD.

72 hours after lung transplantation, patients, whose clinical condition allow to bring them to nuclear medicine department, will undergo pulmonary computed tomography (CT) to study lung morphology and measure lung recruitability and positron emission tomography (PET) to study lung functionality and estimate lung inflammation.

Aim of this study is to investigate the onset of PGD and other complications and to determine 72 hours and 90 days mortality after lung transplantation. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Disorder Related to Lung Transplantation

NCT number NCT01746914
Study type Observational
Source Policlinico Hospital
Contact
Status Completed
Phase N/A
Start date January 2013
Completion date January 2016

See also
  Status Clinical Trial Phase
Completed NCT01915082 - Peri-operative Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation Phase 4
Completed NCT02744872 - Copenhagen Acute Renal Complications After Transplantations Study Group Phase 4
Withdrawn NCT02395393 - Confocal Fluorescence Microscopy of the Human Airways in Diagnostics of Lung Transplantation N/A
Completed NCT02262299 - European Trial of Pirfenidone in BOS, A European Multi-center Study Phase 2/Phase 3
Withdrawn NCT04415476 - Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS) Phase 2
Completed NCT01650545 - Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients Phase 1/Phase 2
Completed NCT01967953 - Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation Phase 1
Completed NCT02363959 - Hyperbaric Oxygen Therapy for Lung Transplantation Phase 2
Completed NCT01793246 - Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung N/A
Recruiting NCT00177918 - Prospective Evaluations of Infectious Complication in Lung Transplant Recipients
Terminated NCT03473340 - Studying the Treatment Effect of Pirfenidone in Chronic Lung Allograft Dysfunction (STOP-CLAD) Phase 2
Not yet recruiting NCT02380365 - QT-Prolongation in Lung Transplantation N/A